Gyre Therapeutics, Inc. GYRE Market capitalization

Market capitalization at other companies

Eli LillyLLY

$1.07T+53.1%

Madrigal Pharmaceuticals, Inc.MDGL

$12.38B+95.6%

Viking TherapeuticsVKTX

$3.76B+38.7%

Theravance BiopharmaTBPH

$881.08M+65.1%

Rigel PharmaceuticalsRIGL

$499.51M+55.4%

Zevra Therapeutics, Inc.ZVRA

$847.71M+69.4%

FAQ

What is Gyre Therapeutics, Inc.'s market capitalization?

Gyre Therapeutics, Inc. (GYRE) reported market capitalization of $734.71M in Q2 2026.

How has Gyre Therapeutics, Inc.'s market capitalization changed year-over-year?

Gyre Therapeutics, Inc.'s market capitalization increased by 6.5% year-over-year, from $689.9M to $734.71M.

What is the long-term trend for Gyre Therapeutics, Inc.'s market capitalization?

Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s market capitalization has grown at a -41.2% compound annual growth rate (CAGR), from $1.97B to $680.11M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.